Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

Clinical trial NCT06055738 · RECRUITING

Trial details

NCT number: NCT06055738
Sponsor: Tang-Du Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cervical Cancer

Start date: 2023-10-09
Primary completion: 2026-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.